Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T29534 |
ABT-925 fumarate dihydrate
ABT 925,LU201640,ABT925,ABT-925,BSF201640,DAT201 |
||
ABT-925 is a selective dopamine D3 receptor (DRD3) antagonist with an in vitro affinity approximately 100 times higher for dopamine D3 receptors than for D2 receptors. | |||
T10213 |
A-437203
ABT-925,A37203,Lu201640 |
Dopamine Receptor | GPCR/G Protein; Neuroscience |
A-437203 (Lu201640) 是一种基于1H-pyrimidin-2-one scaffold 的、具有选择性的、新型强效的d3受体拮抗剂,对 D2, D3, 和 D4 受体,的Ki 值分别为 71, 1.6 和 6220 nM。 | |||
T69808 |
ABT-925 fumarate
|
||
ABT-925, also known as A-37203, BSF-201640; DAT-201; Lu-201640; and A-437203, is a selective dopamine D3 receptor (DRD3) antagonist with an approximately 100-fold higher in vitro affinity for dopamine D₃ versus D₂ receptors. ABT-925 was tested in schizophrenia. ABT-925 is a selective dopamine D₃ receptor antagonist with an approximately 100-fold higher in vitro affinity for dopamine D₃ versus D₂ receptors. |